The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bayer; GlaxoSmithKline; Pharmamar-zeltia
Consulting or Advisory Role - Ayala Pharmaceuticals; Bayer; Blueprint Medicines; Boehringer Ingelheim; GlaxoSmithKline; SpringWorks Therapeutics
Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).
 
Peter Reichardt
Honoraria - Boehringer Ingelheim (Inst); Clinigen Group (Inst); Deciphera (Inst); PharmaMar (Inst)
Consulting or Advisory Role - Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Mundipharma (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst)
Research Funding - Novartis (Inst)
 
Dimosthenis Andreou
Speakers' Bureau - PharmaMar
 
Anne Flörcken
Research Funding - PixCell Medical
 
Thorben Groß
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Stephan Richter
Stock and Other Ownership Interests - Daiichi Sankyo/UCB Japan
Honoraria - PharmaMar
Consulting or Advisory Role - Bayer Germany; Boehringer Ingelheim; Deciphera; PharmaMar
Research Funding - Boehringer Ingelheim (Inst); Deciphera (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Torsten Kessler
No Relationships to Disclose
 
Martin Kortüm
Honoraria - Abbvie; BMS; GlaxoSmithKline; Janssen medical Affairs; Sanofi
Consulting or Advisory Role - Abbvie; BMS; GlaxoSmithKline; Janssen medical Affairs; Sanofi; Skyline Diagnostics
Research Funding - Janssen
Travel, Accommodations, Expenses - Janssen
 
Christian Andreas Schmidt
Travel, Accommodations, Expenses - Amgen (Inst)
 
Bernd Kasper
No Relationships to Disclose
 
Eva Wardelmann
Leadership - German Sarcoma Foundation
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Novartis; PharmaMar; Roche
Research Funding - Institut für Klinische Krebsforschung GmbH; PharmaMar; QuiP
Other Relationship - International Academy of Pathology (IAP)
 
Atzler Benedict
No Relationships to Disclose
 
Disorn Sookthai
Stock and Other Ownership Interests - Bayer
 
Daniel Wilhelm Mueller
No Relationships to Disclose
 
Daniel Pink
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Deciphera (Inst); PharmaMar (Inst)
Speakers' Bureau - PharmaMar (Inst)
Research Funding - Bristol-Myers Squibb (Inst); EUSA Pharma (Inst); PharmaMar (Inst); Roche (Inst)